Jose Chang Selected Research

leridistim

10/2002

Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jose Chang Research Topics

Disease

6	Breast Neoplasms (Breast Cancer) 09/2010 - 10/2002
3	Neoplasms (Cancer) 04/2005 - 01/2004
2	Anemia 04/2005 - 01/2004
1	Cardiotoxicity 02/2008
1	Heart Failure 02/2008
1	Fatigue 04/2005
1	Neoplasm Metastasis (Metastasis) 01/2004
1	Neutropenia 10/2002
1	Febrile Neutropenia 10/2002

Drug/Important Bio-Agent (IBA)

3	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2008 - 10/2002
2	1-dodecylpyridoxal (PLD)IBA 08/2008 - 02/2008
2	Epoetin Alfa (Epogen)FDA Link 04/2005 - 01/2004
1	Fulvestrant (Faslodex)FDA Link 09/2010
1	Estrogen ReceptorsIBA 09/2010
1	liposomal doxorubicin (Doxil)FDA Link 08/2008
1	AnthracyclinesIBA 02/2008
1	Hemoglobins (Hemoglobin)IBA 04/2005
1	Erythropoietin FDA Link 01/2004
1	Clodronic Acid (Clodronate)IBA 01/2004
1	Diphosphonates (Bisphosphonates)IBA 01/2004
1	Pamidronate (Aredia)FDA LinkGeneric 01/2004
1	Docetaxel (Taxotere)FDA Link 10/2002
1	Filgrastim (Neupogen)FDA Link 10/2002
1	myelopoietinIBA 10/2002
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2002
1	leridistimIBA 10/2002
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2002
1	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 10/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 08/2008 - 10/2002
4	Therapeutics 02/2008 - 10/2002
1	Radiotherapy 01/2004